Ciphergen Biosystems, Inc. Announces Issuance of 2nd Quarter 2006 Financial Results and Events
August 04 2006 - 3:26PM
PR Newswire (US)
FREMONT, Calif., Aug. 4 /PRNewswire-FirstCall/ -- Ciphergen
Biosystems, Inc. (NASDAQ:CIPH), will announce 2nd Quarter 2006
Financial Results and Events on Monday, August 14, 2006 after
market close. At 5:00 p.m. EDT on the same day Ciphergen will host
its Quarterly Conference Call to discuss 2nd Quarter 2006 Financial
Results and Events. This call is being webcast by PR Newswire and
can be accessed at Ciphergen's web site at
http://www.ciphergen.com/ Additionally, a telephone replay of the
teleconference will be available for 2 weeks beginning at 7:00 p.m.
(EDT) on Monday, August 14, 2006, and can be accessed by dialing
Domestic: 800 633 8284 or International (+ 1 402 977 9140),
Reservation # 21300833. When: Monday, August 14, 2006 at 5:00 EDT
Where: http://www.ciphergen.com/ How: Live over the Internet --
Simply log on to the web at the address above. Contact: Media
Relations person of Ciphergen Biosystems, Inc. Sue Carruthers, Tel:
510 505 2297 http://www.ciphergen.com/. If you are unable to
participate during the live webcast, the call will be archived on
the Web site http://www.ciphergen.com/ Ciphergen is dedicated to
the discovery of protein biomarkers and panels of biomarkers and
their development into protein molecular diagnostic tests that
improve patient care; and to providing collaborative R&D
services through its Biomarker Discovery Center(R) laboratories for
biomarker discovery for new diagnostic tests as well as
pharmacoproteomic services for improved drug toxicology, efficacy
and theranostic assays. Ciphergen develops, manufactures and
markets a family of ProteinChip(R) Systems and services for
clinical, research and process proteomics applications. ProteinChip
Systems enable protein discovery, validation, identification and
assay development to provide researchers with predictive,
multi-marker assay capabilities and a better understanding of
biological function at the protein level. Additional information
about Ciphergen can be found at DATASOURCE: Ciphergen Biosystems,
Inc. CONTACT: Sue Carruthers of Ciphergen Biosystems, Inc.,
+1-510-505-2297 Web site: http://www.ciphergen.com/
Copyright
Ciphergen Biosystems (NASDAQ:CIPH)
Historical Stock Chart
From Jun 2024 to Jul 2024
Ciphergen Biosystems (NASDAQ:CIPH)
Historical Stock Chart
From Jul 2023 to Jul 2024